Host- and microbe-related risk factors for and pathophysiology of fatal Rickettsia conorii infection in Portuguese patients

Journal of Infectious Diseases

Volumn 198, Issue 4, 2008, Pages 576-585

  De Sousa, Rita ^a   França, Ana ^c   Nòbrega, Sónia Dória ^d   Belo, Adelaide ^e   Amaro, Mario ^c   Abreu, Tiago ^f   Poças, José ^g   Proença, Paula ^h   Vaz, José ^e   Torgal, Jorge ^b   Bacellar, Fátima ^a   Ismail, Nahed ⁱ   Walker, David H ⁱ  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b Faculdade de Ciências Médicas de Lisboa   (Brazil)

^c HOSPITAL GARCIA DE ORTA   (Portugal)

^d HOSPITAL FERNANDO FONSECA   (Portugal)

^e Centro Hospitalar do Baixo Alentejo   (Portugal)

^f Hospital do Espirito Santo   (Portugal)

^g Centro Hospitalar de Setubal   (Portugal)

^h HOSPITAL DE FARO   (Portugal)

ⁱ University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; GAMMA GLUTAMYLTRANSFERASE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOLISM; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL STRAIN; BLOOD CLOTTING DISORDER; CHILD; CONSCIOUSNESS DISORDER; CREATINE KINASE BLOOD LEVEL; DEHYDRATION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HEPATOMEGALY; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOST PATHOGEN INTERACTION; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; INFANT; INFECTION RISK; INTENSIVE CARE UNIT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTPATIENT; PATHOPHYSIOLOGY; PETECHIA; PORTUGAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; RICKETTSIA CONORII; RICKETTSIOSIS; RISK ASSESSMENT; TACHYPNEA; UNIVARIATE ANALYSIS; UREMIA;

BOUTONNEUSE FEVER; COMORBIDITY; HUMANS; KIDNEY FAILURE, ACUTE; MULTIVARIATE ANALYSIS; PORTUGAL; PROSPECTIVE STUDIES; RICKETTSIA CONORII; RICKETTSIA INFECTIONS; RISK FACTORS;

EID: 48749085325     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/590211     Document Type: Article

References (32)

1. Zhu Y, Fournier PE, Eremeeva M, Raoult D. Proposal to create subspecies of Rickettsia conorii based on multi-locus sequence typing and an emended description of Rickettsia conorii. BMC Microbiol 2005; 5:11.
2. Walker DH, Feng HM, Saada JI, et al. Comparative antigenic analysis of spotted fever group from Israel and other closely related organisms. Am J Trop Med Hyg 1995; 52:569-76.
3. Sousa R, Ismail N, Dória-Nóbrega S, et al. The presence of eschars, but not greater severity, in Portuguese patients infected with Israeli spotted fever. Ann N Y Acad Sci 2005; 1063:197-202.
4. Sousa R, Dória S, Bacellar F, Torgal J. Mediterranean spotted fever in Portugal: risk factors for fatal outcome in 105 hospitalized patients. Ann N Y Acad Sci 2003; 990:285-94.
5. Amaro M, Bacellar F, Franca A. Report of eight cases of fatal and severe Mediterranean spotted fever in Portugal. Ann N Y Acad Sci 2003; 990:331-43.
6. Administração Central do Sistema de Saúde, Portuguese Ministry of Health. http://www.acss.min-saude.pt. Accessed 18 June 2008.
7. Bacellar F, Beati L, Franca A, Pocas J, Regnery R, Filipe A. Israeli spotted fever Rickettsia (Rickettsia conorii complex) associated with human diseases in Portugal. Emerg Infect Dis 1999; 5:835-6.
8. Gross EM, Yagupsky P, Torok V, Goldwasser RA. Resurgence of Mediterranean spotted fever. Lancet 1982; 2:1107.
9. Regev-Yochay G, Segal E, Rubinstein E. Glucose-6-phosphate dehydrogenase deficiency: possible determinant for a fulminant course of Israeli spotted fever. Isr Med Assoc J 2000; 2:781-2.
10. Gross EM, Yagupsky P. Israeli rickettsial spotted fever in children: a review of 54 cases. Acta Trop 1987; 44:91-6.
11. Sousa R, Barata C, Vitorino L, et al. Rickettsia sibirica isolation from a patient and detection in ticks, Portugal. Emerg Infect Dis 2006; 12:1103-8.
12. La Scola B, Raoult D. Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol 1997; 35:2715-27.
13. Bacellar F, Sousa R, Santos A, Santos-Silva M, Parola P. Boutonneuse fever in Portugal: 1995-2000. Data of a state laboratory. Eur J Epidemiol 2003; 18:275-7.
14. Cwikel BJ, Ighbarieh J, Sarov I. Antigenic polypeptides of Israeli spotted fever isolates compared with other spotted fever group . Ann N Y Acad Sci 1990; 590:381-8.
15. Goldwasser RA, Klingberg W, Steiman Y, Swartz TA. The isolation of strains of rickettsiae of the spotted fever group in Israel and their differentiation from other members of the group by immunofluorescence methods. Scand J Infect Dis 1974; 6:53-6.
16. Radulovic S, Feng H-M, Morovic M, et al. Isolation of Rickettsia akari from a patient in a region where Mediterranean spotted fever is endemic. Clin Infect Dis 1996; 22:216-20.
17. Vitale G, Mansueto S, Rolain JM, Raoult D. Rickettsia massiliae human isolation. Emerg Infect Dis 2006; 12:174-175.
18. Giammanco GM, Vitale G, Mansueto S, Capra G, Caleca MP, Ammatuna P. Presence of Rickettsia conorii subsp. israelensis, the causative agent of Israeli spotted fever, in Sicily, Italy, ascertained in a retrospective study. J Clin Microbiol 2005; 43:6027-31.
19. Raoult D, Zuchelli P, Weiller PJ, et al. Incidence, clinical observations and risk factors in the severe form of Mediterranean spotted fever among patients admitted to hospital in Marseilles 1983-1984. J Infect 1986; 12:111-6.
20. De Sousa R, Ismail N, Nobrega SD, et al. Intralesional expression of mRNA of interferon-γ, tumor necrosis factor-α, interleukin-10, nitric oxide synthase, indoleamine-2, 3-dioxygenase, and RANTES is a major immune effector in Mediterranean spotted fever rickettsiosis. J Infect Dis 2007; 196:770-81.
21. Walker DH, Staiti A, Mansueto S, Triangali G. Frequent occurrence of hepatic lesions in boutonneuse fever. Acta Trop 1986; 43:175-81.
22. Walker DH, Mattern WD. Acute renal failure in Rocky Mountain spotted fever. Arch Intern Med 1979; 139:443-48.
23. Font-Creus B, Bella-Cueto F, Espejo-Arenas E, et al. Mediterranean spotted fever: a cooperative study of 227 cases. Rev Infect Dis 1985; 7:635-42.
24. Jado I, Oteo J, Aldámiz M, et al. Rickettsia monacensis and human disease, Spain. Emerg Infect Dis 2007; 13:1405-7.
25. De Sousa R, Santos- Silva M, Santos AS, et al. Rickettsia conorii Israeli tick typhus strain isolated from Rhipicephalus sanguineus ticks in Portugal. Vector Borne Zoonotic Dis 2007; 7:444-47.
26. Li H, Walker DH. rOmpA is a critical protein for the adhesion of Rickettsia rickettsii to host cells. Microbial Pathogen 1998; 24:289-298.
27. Martinez JJ, Seveau S, Veiga E, Matsuyama S, Cossart P. Ku70, a component of DNA-dependent protein kinase, is a mammalian receptor for Rickettsia conorii. Cell 2005; 123:1013-23.
28. Uchiyama T, Kawano H, Kusuhara Y. The major outer membrane protein rOmpB of spotted fever group rickettsiae functions in the rickettsial adherence to and invasion of Vero cells. Microbes Infect 2006; 8:801-9.
29. Gouin E, Egile C, Dehoux P, et al. The RickA protein of Rickettsia conorii activates the Arp2/3 complex. Nature 2004; 427:457-61.
30. Renesto P, Dehoux P, Gouin E, Touqui L, Cossart P, Raoult D. Identification and characterization of a phospholipase D-superfamily gene in rickettsiae. J Infect Dis 2003; 188:1276-83.
31. Whitworth T, Popov VL, Yu X-J, Walker DH, Bouyer DH. Expression of the Rickettsia prowazekii pld or tlyC gene in Salmonella enterica serovar typhimurium mediates phagosomal escape. Infect Immun 2005; 73:6668-73.
32. Radulovic S, Troyer JM, Beier MS, Lau AOT, Azad AF. Identification and molecular analysis of the gene encoding Rickettsia typhi hemolysin. Infect Immun 1999; 67:6104-8.